Massachusetts General Hospital - Cancer Center — Boston, Massachusetts

Massachusetts General Hospital - Cancer Center is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Massachusetts General Hospital - Cancer Center has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: Rhabdoid Tumors, INI1-negative Tumors, Synovial Sarcoma.

Sponsors: Epizyme, Inc., Bioverativ, a Sanofi company, Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts General Hospital - Cancer Center?

Massachusetts General Hospital - Cancer Center has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts General Hospital - Cancer Center conducted?

Massachusetts General Hospital - Cancer Center has 4 clinical trials on record, with 1 currently active. Their work covers Rhabdoid Tumors, INI1-negative Tumors, Synovial Sarcoma.

Is Massachusetts General Hospital - Cancer Center accredited by Crixeo Health?

Yes — Massachusetts General Hospital - Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Massachusetts General Hospital - Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.